Search results
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSutro Biopharma, Inc. (STRO) delivered earnings and revenue surprises of -146.67% and 121.56%,...
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift...
Simply Wall St. via Yahoo Finance· 6 months agoSutro Biopharma, Inc. (NASDAQ:STRO) shares have had a really impressive month, gaining 48% after a...
Sutro Biopharma, Inc. (STRO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks via Yahoo Finance· 1 year agoSutro Biopharma, Inc. (STRO) doesn't possess the right combination of the two key ingredients for a...
Shareholders Will Likely Find Sutro Biopharma, Inc.'s (NASDAQ:STRO) CEO Compensation Acceptable
Simply Wall St. via Yahoo Finance· 1 week agoKey Insights Sutro Biopharma to hold its Annual General Meeting on 6th of June Total pay for CEO...
Sutro Biopharma, Inc. (NASDAQ:STRO) insider upped their holding by 4.3% earlier this year
Simply Wall St. via Yahoo Finance· 1 year agoLooking at Sutro Biopharma, Inc.'s (NASDAQ:STRO ) insider transactions over the last year, we can...
Sutro Biopharma, Inc. (STRO) Soars 11.3%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 1 year agoSutro Biopharma, Inc. (STRO) saw its shares surge in the last session with trading volume being...
Is Sutro Biopharma (NASDAQ:STRO) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 2 years agoSome say volatility, rather than debt, is the best way to think about risk as an investor, but...
Sutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration
Zacks via Yahoo Finance· 2 years agoSutro Biopharma (STRO) inks a partnership and licensing deal with Astellas Pharma to discover and...
Investors in Sutro Biopharma (NASDAQ:STRO) have unfortunately lost 51% over the last three years
Simply Wall St. via Yahoo Finance· 1 year agoSutro Biopharma, Inc. (NASDAQ:STRO) shareholders should be happy to see the share price up 15% in...
With 74% ownership of the shares, Sutro Biopharma, Inc. (NASDAQ:STRO) is heavily dominated by...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Sutro Biopharma, Inc. (NASDAQ:STRO), then you'll have to...